Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily ...

Experts say that the gene therapy could prove 'transformative' for patients by preventing future heart attacks or strokes.

Switching from daily pills for life to a single injection could revolutionise cholesterol treatment, especially for those ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A groundbreaking gene therapy, VERVE-102, has shown promise in reducing "bad" cholesterol by up to 62% with a single ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal ...

LOS ANGELES (Reuters) -Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol-lowering medication Repatha at a discounted cash price, becoming the latest pharmaceutical company to ...

LLY's stock is still down year-to-date as AI-driven narratives have captured the bulk of investor attention and capital in 2026.

Very high levels are even more dangerous than better-known risks for heart-attack and stroke. “In individuals who don’t have heart disease, it seems it is equivalent to having two other modifiable ...